Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,470
datasets available to search
ShareScore release 0.9.0
Dataset results
2,470 results for “Acute Myeloid Leukemia”
Imatinib Mesylate, Daunorubicin, and Cytarabine in Treating Patients With Relapsed Acute Myeloid Leukemia
ClinicalTrials.gov study NCT00268229. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Azacitidine, Mitoxantrone Hydrochloride, and Etoposide in Treating Older Patients With Poor-Prognosis Acute Myeloid Leukemia
ClinicalTrials.gov study NCT01260714. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Trebananib With or Without Low-Dose Cytarabine in Treating Patients With Acute Myeloid Leukemia
ClinicalTrials.gov study NCT01555268. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Dual Growth Factor (rhTPO + G-CSF) and Chemotherapy Combination Regimen in Acute Myeloid Leukemia: Study Protocol for a Randomized Controlled Trial
ClinicalTrials.gov study NCT05382390. IPD Sharing: NO. Countries: 1. Publications: 0.
Intensive Therapy Combined With Venetoclax for Adult Acute Myeloid Leukemia
ClinicalTrials.gov study NCT05356169. IPD Sharing: Not stated. Countries: 1. Publications: 0.
TP-0903 for the Treatment of FLT3 Mutated Acute Myeloid Leukemia
ClinicalTrials.gov study NCT04518345. IPD Sharing: NO. Countries: 1. Publications: 0.
Bortezomib, Mitoxantrone, Etoposide, and Cytarabine in Relapsed or Refractory Acute Myeloid Leukemia
ClinicalTrials.gov study NCT01127009. IPD Sharing: Not stated. Countries: 1. Publications: 0.
QUILT-3.018: Neukoplast™ (NK-92) for the Treatment of Refractory or Relapsed Acute Myeloid Leukemia
ClinicalTrials.gov study NCT00900809. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of JNJ-89853413 for Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Neoplasms
ClinicalTrials.gov study NCT06618001. IPD Sharing: YES. Countries: 3. Publications: 0.
Repurposing Itraconazole as an Adjuvant Therapy in Treatment of Patients With Acute Myeloid Leukemia: Is it a Hopeful Avenue for Enhancing Treatment Options?
ClinicalTrials.gov study NCT07069933. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Dose Escalation and Expansion Study to Evaluate the Safety, PK, PD and Efficacy of ZE46-0134 in Adults With FLT3 Mutated or Spliceosome Mutated Relapsed or Refractory Acute Myeloid Leukemia
ClinicalTrials.gov study NCT06366789. IPD Sharing: Not stated. Countries: 4. Publications: 0.
Randomization for the Identification of Best Treatment Intensity for Less Fit Adults With Acute Myeloid Leukemia and Myeloid Neoplasms
ClinicalTrials.gov study NCT07094750. IPD Sharing: NO. Countries: 1. Publications: 0.
An Open-Label, Phase I/II Study of Nilotinib (Tasigna) and MEK-162 (ARRY-162) Used in Combination for Patients With Refractory or Advanced Chronic Myeloid Leukemia and Philadelphia Positive Acute Leuk
ClinicalTrials.gov study NCT02225574. IPD Sharing: Not stated. Countries: 1. Publications: 0.
CRISPR-Edited Allogeneic Anti-CLL-1 CAR-T Cell Therapy in Patients With Relapsed/Refractory Acute Myeloid Leukemia
ClinicalTrials.gov study NCT06128044. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study the Novel Functions and Molecular Mechanisms of Vascular Endothelial Growth Factor-C (VEGF-C) in Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT01195506. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Mitoxantrone for Venetoclax Resistant Acute Myeloid Leukemia
ClinicalTrials.gov study NCT06429449. IPD Sharing: NO. Countries: 1. Publications: 0.
Phase I Study of HMPL-523+Azacitidine in Elderly Patients With Acute Myeloid Leukemia
ClinicalTrials.gov study NCT03483948. IPD Sharing: NO. Countries: 1. Publications: 0.
Study of Low-Dose Cytarabine and Etoposide With or Without All-Trans Retinoic Acid in Older Patients Not Eligible for Intensive Chemotherapy With Acute Myeloid Leukemia and NPM1 Mutation
ClinicalTrials.gov study NCT01237808. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Orca-T Following Chemotherapy and Total Marrow and Lymphoid Irradiation for the Treatment of Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia or Myelodysplastic Syndrome
ClinicalTrials.gov study NCT06195891. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Decitabine Versus Conventional Chemotherapy for Maintenance Therapy of Acute Myeloid Leukemia With t(8;21)
ClinicalTrials.gov study NCT03026842. IPD Sharing: NO. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.